Cargando…
LDL-cholesterol reduction in patients with hypercholesterolemia by modulation of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase
PURPOSE OF REVIEW: To review the profile of ETC-1002, as shown in preclinical and clinical studies, including LDL-cholesterol (LDL-C)-lowering activity and beneficial effects on other cardiometabolic risk markers as they relate to the inhibition of adenosine triphosphate-citrate lyase and the activa...
Autores principales: | Filippov, Sergey, Pinkosky, Stephen L., Newton, Roger S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162331/ https://www.ncbi.nlm.nih.gov/pubmed/24978142 http://dx.doi.org/10.1097/MOL.0000000000000091 |
Ejemplares similares
-
Cardiovascular diseases in mega-countries: the challenges of the nutrition, physical activity and epidemiologic transitions, and the double burden of disease
por: Barquera, Simon, et al.
Publicado: (2016) -
Effects of melatonin on cardiovascular diseases: progress in the past year
por: Sun, Hang, et al.
Publicado: (2016) -
Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis
por: Pinkosky, Stephen L., et al.
Publicado: (2016) -
Computerized Modeling of Adenosine Triphosphate, Adenosine Triarsenate and Adenosine Trivanadate
por: Nascimento, Valter A., et al.
Publicado: (2012) -
Enhanced Production of Adenosine Triphosphate by Pharmacological Activation of Adenosine Monophosphate-Activated Protein Kinase Ameliorates Acetaminophen-Induced Liver Injury
por: Hwang, Jung Hwan, et al.
Publicado: (2015)